尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Scadden David, 董事. Officer active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. Cumulatively, 13 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €48k. History available since 28 May 2021. The latest transaction was disclosed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Scadden David is Administrateur at AGIOS PHARMACEUTICALS, INC. and Agios Pharmaceuticals, INC. He has 13 filings in total, and in the sampled recent filings, the activity spans 2021-06-02 to 2026-06-23, with EUR 0 in buys and EUR 47852 in sales. The most frequent transaction nature is Levée d'options.